Thyroid stimulating hormone, independent of thyroid hormone, can elevate the serum total cholesterol level in patients with coronary heart disease: A cross-sectional design

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Xu, Chao ^a,c   Yang, Xiaomei ^a   Liu, Wenhui ^b   Yuan, Haitao ^a   Yu, Chunxiao ^a,c   Gao, Ling ^a,c   Zhao, Jiajun ^a,c  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c Shandong Academy of Clinical Medicine   (China)

Author keywords

Cholesterol; Coronary heart disease; TSH

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID HORMONE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTHYROIDISM; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; THYROID DISEASE; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84861334632     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-44     Document Type: Article

References (31)

1. Thyroid hormone and the cardiovascular system. Klein I, Ojamaa K, N Engl J Med 2001 344 501 509 10.1056/NEJM200102153440707 11172193
2. Thyroid disease and lipids. Duntas LH, Thyroid 2002 12 287 293 10.1089/10507250252949405 12034052
3. Hypothyroidism as a risk factor for cardiovascular disease. Biondi B, Klein I, Endocrine 2004 24 1 13 10.1385/ENDO:24:1:001 15249698
4. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N, Ann Intern Med 2008 148 832 845 18490668
5. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V, Arch Intern Med 2005 165 2467 2472 10.1001/archinte.165.21.2467 16314542
6. An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters: a study in healthy women. Waterhouse DF, McLaughlin AM, Walsh CD, Sheehan F, OShea D, Thyroid 2007 17 243 248 10.1089/thy.2006.0208 17381358
7. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. Roos A, Bakker S, Links T, Gans R, Wolffenbuttel B, J Clin Endocrinol Metab 2007 92 491 496 17090642
8. Thyroid functions and serum lipids in older women: a population-based study. Bauer DC, Ettinger B, Browner WS, Am J Med 1998 104 546 551 10.1016/S0002-9343(98)00116-8 9674717
9. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ, JAMA 2004 291 228 238 10.1001/jama.291.2.228 14722150
10. Subclinical Hypothyroidism and the Risk of Heart Failure, Other Cardiovascular Events, and Death. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, Bauer DC, Arch Intern Med 2005 165 2460 2466 10.1001/archinte.165.21.2460 16314541
11. Thyroid status, cardiovascular risk and mortality in older adults. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW, JAMA 2006 295 1033 1041 10.1001/jama.295.9.1033 16507804
12. The correlation between thyrotropin and dyslipidemia in a population-based study. Lu L, Wang B, Shan Z, Jiang F, Teng X, Chen Y, Lai Y, Wang J, Xue H, Wang S, Li C, Liu H, Li N, Yu J, Shi L, Hou X, Xing Q, Bai X, Teng W, J Korean Med Sci 2011 26 243 249 10.3346/jkms.2011.26.2.243 21286016
13. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Gardũo-Garcia Jde J, Alvirde-Garcia U, Lápez-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME, Malacara JM, Gomez-Perez FJ, Aguilar-Salinas CA, Eur J Endocrinol 2010 163 273 278 10.1530/EJE-10-0312 20516204
14. Higher serum free thyroxine levels are associated with coronary artery disease. Jung CH, Rhee EJ, Shin HS, Jo SK, Won JC, Park CY, Kim BJ, Sung KC, Kim BS, Lee WY, Oh KW, Kang JH, Park SW, Lee MH, Kim SW, Endocrine J 2008 55 819 826 10.1507/endocrj.K08E-010
15. A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate- responsive element binding protein pathway. Tian L, Song Y, Xing M, Zhang W, Ning G, Li X, Yu C, Qin C, Liu J, Tian X, Sun X, Fu R, Zhang L, Zhang X, Lu Y, Zou J, Wang L, Guan Q, Gao L, Zhao J, Hepatology 2010 52 1401 1409 10.1002/hep.23800 20648556
16. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Circulation 2002 106 25 3143 3421 12485966
17. Physical activity and serum lipids: a cross-sectional population study in Eastern Finnish men. Lakka TA, Salonen JT, Am J Epidemiol 1993 136 806 818
18. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, L'Abbate A, Pingitore A, Arch Intern Med 2007 167 1526 1532 10.1001/archinte.167.14.1526 17646607
19. Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications. Coceani M, Iervasi G, Pingitore A, Carpeggiani C, L'Abbate A, Clin Cardiol 2009 32 380 385 10.1002/clc.20574 19609889
20. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. Iqbal A, Jorde R, Figenschau Y, J Intern Med 2006 260 53 61 10.1111/j.1365-2796.2006.01652.x 16789979
21. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Jung CH, Sung KC, Shin HS, Rhee EJ, Lee WY, Kim BS, Kang JH, Kim H, Kim SW, Lee MH, Park JR, Kim SW, Korean J Intern Med 2003 18 146 153 14619383
22. Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey. Diehl LA, Garcia V, Bonnema SJ, Hegedüs L, Albino CC, Graf H, Latin American Throid Society, Latin American Throid Society, J Clin Endocrinol Metab 2005 90 117 123 15483102
23. Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. Fernández-Real JM, Lápez-Bermejo A, Castro A, Casamitjana R, Ricart W, J Clin Endocrinol Metab 2006 91 3337 3343 10.1210/jc.2006-0841 16804039
24. Thyroid diseases, dyslipidemia and cardiovascular pathology. Neves C, Alves M, Medina JL, Delgado JL, Rev Port Cardiol 2008 27 1211 1236 19178025
25. Low-density lipoprotein cholesterol in subclinical hypothyroidism. Vierhapper H, Nardi A, Grösser P, Raber W, Gessl A, Thyroid 2000 10 981 984 10.1089/thy.2000.10.981 11128726
26. Thyroid hormone and lipid metabolism in a group of patients over seventy. Maugeri D, Santangelo A, Barbagallo P, Bonanno MR, Malaguarnera M, Rizza I, Speciale S, Tomarchio M, Curas MP, Panebianco P, Eur Rev Med Pharmacol Sci 1999 3 211 216 11075619
27. Extrathyroidal expression of TSH receptor. Williams GR, Ann Endocrinol (Paris) 2011 72 68 73 10.1016/j.ando.2011.03.006
28. Presence of thyrotropin receptor in hepatocytes: not a case of illegitimate transcription. Zhang W, Tian LM, Han Y, Ma HY, Wang LC, Guo J, Gao L, Zhao JJ, J Cell Mol Med 2009 13 4636 4642 10.1111/j.1582-4934.2008.00670.x 19187127
29. TSH stimulates adipogenesis in mouse embryonic stem cells. Lu M, Lin RY, J Endocrinol 2008 196 159 169 10.1677/JOE-07-0452 18180327
30. Thyroid-stimulating hormone stimulates lipolysis in adipocytes in culture and raises serum free fatty acid levels in vivo. Gagnon A, Antunes TT, Ly T, Pongsuwan P, Gavin C, Lochnan HA, Sorisky A, Metabolism 2010 59 547 553 10.1016/j.metabol.2009.08.018 19846175
31. Santini F, Galli G, Castagna M.G,Checchi S, Molinaro E.Acute exogenous TSH administration stimulates leptin secretion in vivo, Eur J Endocrinol 2010 163 63-67, 10.1530/EJE-10-0138 20392823